Clinical trials recruiting for Homozygous Familial Hypercholesterolemia (HoFH)
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| CTX310 | 1 |
| EDP167 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Florida | 1 |
| New York | 1 |
| North Carolina | 1 |
| Oregon | 1 |
| Wisconsin | 1 |
Top cities
Self-screener
Recruiting trials
- A Dose-exploration Study of EDP167 in HoFH
- A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
- Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Coronary Plaque Volumes Measured by Coronary Computed Tomography Angiography (CCTA) in Patients With Homozygous Familial Hypercholesterolemia (HoFH)
- The ORIGIN-FH Study
Related conditions
Trials recruiting for Homozygous Familial Hypercholesterolemia (HoFH) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Homozygous Familial Hypercholesterolemia (HoFH) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.